3 Hyperlipidaemia in diabetes

Bailliere's Clinical Endocrinology and Metabolism

Volumn 4, Issue 4, 1990, Pages 743-775

  Taskinen, Marja Riitta ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BEZAFIBRATE; COLESTIPOL; COLESTYRAMINE; FENOFIBRATE; FLUINDOSTATIN; GEMFIBROZIL; INSULIN; MEVINOLIN; SIMVASTATIN;

DIET; HUMAN; HYPERLIPIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

APOLIPOPROTEINS; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; HUMAN; HYPERLIPIDEMIA; LIPOPROTEINS; SUPPORT, NON-U.S. GOV'T;

EID: 0025636047     PISSN: 0950351X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0950-351X(05)80078-3     Document Type: Article

References (140)

1. Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population
2. Nutritional recommendations and principles for individuals with diabetes mellitus
3. Improved diabetic control and hypo-cholesterolaemic effect induced by long-term dietary supplementation with guar gum in type 2 (insulin-independent) diabetes
4. The prospective cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease
5. Whole-plasma and high-density lipoprotein subfraction surface lipid composition in IDDM men
6. Abnormal high-density lipoprotein composition in women with insulin-dependent diabetes
7. Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy
8. Plasma lipids and diabetes mellitus in an adult community
9. The correlation of arteriosclerosis obliterans with lipoproteins in insulin-dependent and non-insulin-dependent diabetes
10. Lipoprotein subfraction composition in non-insulin-dependent diabetes treated by diet, sulphonylurea, and insulin
11. Lipids, lipoproteins and apolipoproteins in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus
12. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women
13. Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics
14. Low density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation
15. Chylomicronemia syndrome in diabetes mellitus
16. Oxidized LDL cytotoxicity in experimental diabetes: effects of antioxidants
17. Changes in plasma lipoprotein lipids in hyper-cholesterolemic patients treated with the bile acid-sequestering resin, colestipol
18. Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells
19. Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria
20. Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type 1 diabetes mellitus
21. The effect of diabetic control on very low-density lipoprotein—triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia
22. Treatment with artificial β-cell decreases very-low-density lipoprotein triglyceride synthesis in type I diabetes
23. Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes
24. High density lipoprotein composition in insulin-dependent diabetes mellitus
25. Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer
26. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes
27. Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia
28. Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus
29. Management of dyslipidemia in NIDDM
30. Relationship between lipoprotein levels and in vivo insulin action in normal young white men
31. Hyperlipidaemia of diabetes
32. Very low density lipoprotein metabolism in diabetes mellitus
33. High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL
34. Plasma levels of apoprotein B in patients with diabetes mellitus: the effect of glycemic control
35. Fibric acids: Effects on lipids and lipoprotein metabolism
36. The place of HDL in cholesterol management: a perspective from the National Cholesterol Education Program
37. The diabetes intervention study (DIS): a cooperative multi-intervention trial with newly manifested type II diabetics: preliminary results
38. Plasma HDL-cholesterol and postheparin plasma hepatic endothelial lipase (HL) activity: relationship to obesity and non-insulin dependent diabetes (NIDDM)
39. High density lipoprotein subfractions during continuous insulin infusion therapy
40. Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus
41. Effect of variation in diet on lipoprotein metabolism in patients with diabetes mellitus
42. Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus
43. Ischemic heart disease and its risk factors in insulin-dependent diabetes
44. Lipoprotein metabolism in diabetes mellitus
45. Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes
46. Insulin regulates apolipoprotein B (apo B) turnover and phosphorylation in rat hepatocytes
47. Daily insulin dose as a predictor of macrovascular disease in insulin treated non-insulin-dependent diabetics
48. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors
49. Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased albumin excretion
50. Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM
51. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria
52. Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics
53. Significance of hepatic triglyceride lipase activity in the regulation of serum high density lipoproteins in type II diabetes mellitus
54. Low density lipoprotein metabolism in non-insulin-dependent diabetes mellitus
55. Interaction of very-low-density lipoprotein isolated from type 1 (insulin-dependent) diabetic subjects with human monocyte-derived macrophages
56. Improvement of glucose tolerance in NIDDM by clofibrate: randomized double-blind study
57. Decreased plasma phosphatidylcholine/free cholesterol ratio as an indicator or risk for ischemic vascular disease
58. Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes
59. Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics
60. 2 cholesterol with coronary heart disease in noninsulin-dependent diabetics
61. Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus
62. Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycaemia in obese non-insulin-dependent diabetic subjects
63. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance
64. Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol
65. Effect of different insulin regimens on plasma lipoprotein and apolipoprotein concentrations in patients with non-insulin-dependent diabetes mellitus
66. Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control
67. Effect of metabolic control on lipid, lipoprotein, and apolipoprotein levels in 55 insulin-dependent diabetic patients: a longitudinal study
68. Glycosylation of low-density lipoprotein enhances cholesteryl esterol synthesis in human monocyte-derived macrophages
69. Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control
70. The effect of triglyceride reduction on peripheral insulin sensitivity and glucose and lipid oxidation
71. High density lipoprotein subfractions in insulin-dependent diabetic and normal subjects
72. In vivo stimulation of low-density lipoprotein degradation by insulin
73. Glucose tolerance and plasma insulin in man during acute and chronic administration of nicotinic acid
74. The effect of nicotinic acid in diabetes mellitus
75. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults
76. Plasma lipid and lipoprotein abnormalities in diabetes
77. Serum lipids and lipoproteins in insulin-treated diabetes: demonstration of increased high density lipoprotein concentrations
78. Plasma triglyceride transport kinetics in diabetes mellitus
79. Current issues in nutrition and metabolism
80. Quantitative relationship between plasma lipids and glycohemoglobin in type 1 diabetes
81. Human splanchnic metabolism during diabetic ketoacidosis
82. Role of insulin in lipoprotein secretion by cultured rat hepatocytes
83. The effect of improved diabetic control on plasma lipid and lipoprotein levels: a comparison of conventional therapy and continuous subcutaneous insulin infusion
84. The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus
85. Changes in lipoprotein subfractions in type 1 (insulin-dependent) diabetic patients. Influence of optimal insulin treatment
86. Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics
87. Diabetes and atherosclerosis: an epidemiologic view
88. Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus: pathogenesis and treatment
89. High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus
90. Effects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetes
91. Presence of very low density lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation
92. Effects of long-term physical exercise on serum lipids, lipoproteins and lipid metabolizing enzymes in type 2 (non-insulin-dependent) diabetic patients
93. Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients
94. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study
95. Reduction in cardiovascular risk factors with intensive diabetes treatment in insulin-dependent diabetes mellitus
96. Effect of intensive diabetes treatment on low-density lipoprotein apolipoprotein B kinetics in type I diabetes
97. Effects of intraperitoneal vs subcutaneous insulin administration on lipoprotein metabolism in type I diabetes
98. Verbesserung der Diabeteseinstellung unter der Therapie mit Bezafibrat
99. Association of serum lipids and lipoproteins with plasma C-peptide concentration in non-insulin-dependent diabetic and non-diabetic subjects
100. Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: cholesterol acyltransferase activity in diabetes mellitus
101. Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention
102. An overview of the effects of p-chlorophenoxy-isobutyric acid derivatives on lipoprotein metabolism
103. Membrane fluidity and cellular functions
104. Triglyceride-rich lipoprotein metabolism during acute hyperinsulinemia in hypertriglyceridemic humans
105. Is non-insulin-dependent diabetes mellitus associated with an increase in postprandial retinyl ester concentration?
106. Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes
107. Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men
108. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity
109. Lack of awareness and treatment of hyperlipidemia in type II diabetes in a community survey
110. I
111. Lipoprotein lipase in diabetes
112. Hyperlipidaemia and diabetes: spectrum of lipid disorders in diabetes
113. The role of alcohol in lipoprotein metabolism
114. Enzymes involved in triglyceride hydrolysis
115. Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes: relation to high-density and very-low-density lipoproteins and response to treatment
116. Lipolytic enzymes and HDL: influence of drugs and hormones
117. Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity
118. Regulation of HDL and its subfractions in chronically insulin treated patients with type 1 diabetes
119. Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism: studies before and after sulfonylurea therapy
120. Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes
121. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM
122. Lipid changes in macrovascular disease in diabetes
123. HDL apoprotein A-I and A-II metabolism in IDDM
124. Overview of clinical trials of cholesterol lowering in relationship to epidemiologic studies
125. Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels
126. Lipid abnormalities in insulin-dependent diabetic patients with albuminuria
127. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations
128. Effects of insulin on plasma lipoproteins in diabetic ketoacidosis: evidence for a change in high density lipoprotein composition during treatment
129. Type 1 (insulin-dependent) versus type 2 (non-insulin-dependent) diabetes mellitus: characterization of serum lipoprotein alterations
130. The role of circulating glucose and triglyceride concentrations and their interactions with other ‘risk factors’ as determinants of arterial disease in nine diabetic population samples from the WHO multinational study
131. Lipids, glucose intolerance and vascular disease: the Framingham Study
132. Lipoprotein abnormalities in insulin-dependent diabetes mellitus
133. Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus
134. The prevalence of hyperlipidaemia and related clinical features in insulin-dependent diabetes mellitus
135. Nonenzymatic glucosylation of low density lipoprotein alters its biologic activity
136. Recommendation for strict control of plasma triglyceride in diabetic subjects
137. Long-term treatment of hypercholesterolemic non-insulin-dependent diabetics (NIDDM) with pravastatin (CS-514)
138. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride
139. Insulin action in obese non-insulin-dependent diabetics and in their isolated adipocytes before and after weight loss